Publisher Correction: Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers’ Submissions and a Comparison Between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses

Fatemeh Mirzayeh Fashami (), Jean-Eric Tarride (), Behnam Sadeghirad (), Kimia Hariri (), Amirreza Peyrovinasab () and Mitchell Levine ()
Additional contact information
Fatemeh Mirzayeh Fashami: McMaster University
Jean-Eric Tarride: McMaster University
Behnam Sadeghirad: McMaster University
Kimia Hariri: Mazandaran University of Medical Science
Amirreza Peyrovinasab: Islamic Azad University, Tehran Medical Sciences University (IAUTMU)
Mitchell Levine: McMaster University

PharmacoEconomics - Open, 2024, vol. 8, issue 6, No 16, 963-965

Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s41669-024-00522-6 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharmo:v:8:y:2024:i:6:d:10.1007_s41669-024-00522-6

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/41669

DOI: 10.1007/s41669-024-00522-6

Access Statistics for this article

PharmacoEconomics - Open is currently edited by Timothy Wrightson and Christopher Carswell

More articles in PharmacoEconomics - Open from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().